We all have heard about telomerase and how important it is to the prevention of telomere degradation with each cell division. We also all know that one of the main differences between somatic cells that are have a limit imposed on the number of times they can divide (aka Hayflick limit) and stem cells which do not is the absence of telomerase. Thus we have come to associate the function of telomerase with immortal cells and for those who study oncology, with cancer cells.
New studies, however are underlining another function for telomerase, that of DNA repair:
Introduction of human telomerase reverse transcriptase to normal human fibroblasts enhances DNA repair capacity. Clin Cancer Res. 2004 Apr 1;10(7):2551-60.
In this study it was found that transfection of normal human oral fibroblasts, that are telomerase negative, with a vector containing the telomerase gene resulted in increased survival rates upon exposure to UV. Telomerase was shown to accelerate the rate of DNA repair, a enhancement which was lost when the cell stopped producing telomerase.
The results of this study suggest an additional basis for the increased survival capability of stem cells as being not just associated with telomere maintenance but also of enhanced DNA repair when compared with somatic cells. As we know, impaired DNA repair results in senescence, apoptosis or even cancer. Somatic cells that have no telomerase are thus disadvantaged doubly: no telomere maintenance and no telomerase based DNA repair.
This additional benefit of telomerase now brings to question how strong its association with cancer really is. In other words, is the presence of telomerase the defining difference between the cancer and normal cell? Of course not. We know that there are other even more important factors that define a cancer cell such as indifference to surrounding cells and the extra cellular matrix, potential for migration and abnormal growth factor secretions and responses. Therefore, telomerase should be lowered on the scale of importance in what constitutes a cancer cell and therapeutic strategies are better off focusing on dealing with the migration (malignancy) potential of cancer cells.
Thus another opportunity for therapeutic intervention presents itself with telomerase with the knowledge that it helps to keep cells alive through an additional pathway - that of DNA repair.